期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Metabolic aspects of adult patients with nonalcoholic fatty liver disease 被引量:17
1
作者 Ludovico Abenavoli Natasa Milic +3 位作者 Laura Di Renzo Tomislav Preveden Milica Medi?-Stojanoska Antonino De Lorenzo 《World Journal of Gastroenterology》 SCIE CAS 2016年第31期7006-7016,共11页
Nonalcoholic fatty liver disease(NAFLD) is a major cause of chronic liver disease and it encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, or cirrhosis. The mechanisms involved in the occurren... Nonalcoholic fatty liver disease(NAFLD) is a major cause of chronic liver disease and it encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, or cirrhosis. The mechanisms involved in the occurrence of NAFLD and its progression are probably due to a metabolic profile expressed within the context of a genetic predisposition and is associated with a higher energy intake. The metabolic syndrome(MS) is a cluster of metabolic alterations associated with an increased risk for the development of cardiovascular diseases and diabetes. NAFLD patients have more than one feature of the MS, and now they are considered the hepatic components of the MS. Several scientific advances in understanding the association between NAFLD and MS have identified insulin resistance(IR) as the key aspect in the pathophysiology of both diseases. In the multi parallel hits theory of NAFLD pathogenesis, IR was described to be central in the predisposition of hepatocytes to be susceptible to other multiple pathogenetic factors. The recent knowledge gained from these advances can be applied clinically in the prevention and management of NAFLD and its associated metabolic changes. The present review analyses the current literature and highlights the new evidence on the metabolic aspects in the adult patients with NAFLD. 展开更多
关键词 NONALCOHOLIC FATTY liver disease NONALCOHOLIC STEATOHEPATITIS INSULIN resistance OBESITY METABOLIC syndrome
下载PDF
IS There A Role of 18F-FDG PET/CT for Initial Staging of Rectal Cancer?
2
作者 J. Mihailovic O. Ivanov +1 位作者 N. Prvulovic Bunovic D. Ivanov 《Journal of Pharmacy and Pharmacology》 2017年第12期940-952,共13页
下载PDF
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases 被引量:14
3
作者 Bojan Stanimirov Karmen Stankov Momir Mikov 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2015年第1期18-33,共16页
BACKGROUND: The well-known functions of bile acids(BAs) are the emulsification and absorption of lipophilic xenobiotics. However, the emerging evidences in the past decade showed that BAs act as signaling molecules... BACKGROUND: The well-known functions of bile acids(BAs) are the emulsification and absorption of lipophilic xenobiotics. However, the emerging evidences in the past decade showed that BAs act as signaling molecules that not only autoregulate their own metabolism and enterohepatic recirculation, but also as important regulators of integrative metabolism by activating nuclear and membrane-bound G protein-coupled receptors. The present review was to get insight into the role of maintenance of BA homeostasis and BA signaling pathways in development and management of hepatobiliary and intestinal diseases.DATA SOURCES: Detailed and comprehensive search of PubM ed and Scopus databases was carried out for original and review articles.RESULTS: Disturbances in BA homeostasis contribute to the development of several hepatobiliary and intestinal disorders, such as non-alcoholic fatty liver disease, liver cirrhosis, cholesterol gallstone disease, intestinal diseases and both hepatocellular and colorectal carcinoma.CONCLUSION: Further efforts made in order to advance the understanding of sophisticated BA signaling network may be promising in developing novel therapeutic strategies related not only to hepatobiliary and gastrointestinal but also systemic diseases. 展开更多
关键词 bile acid metabolism non-alcoholic fatty liver disease cholestatic liver diseases gallstone disease intestinal disease hepatocellular carcinoma
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部